(Q33425261)

26 July 2017

Safety and tolerability of tegaserod in patients with irritable bowel syndrome and diarrhea symptoms (English)

1 reference

26 July 2017

0 references

irritable bowel syndrome

1 reference

James Fidelholtz

1

1 reference

26 July 2017

William Smith

2

1 reference

26 July 2017

James Rawls

3

1 reference

26 July 2017

Yingqi Shi

4

1 reference

26 July 2017

Anna Zack

5

1 reference

26 July 2017

Peter Rüegg

6

1 reference

26 July 2017

Martin Lefkowitz

7

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

The American Journal of Gastroenterology

26 July 2017

1 reference

26 July 2017

97

1 reference

26 July 2017

5

1 reference

26 July 2017

1176-1181

1 reference

Patient subgroups in irritable bowel syndrome that can be defined by symptom evaluation and physical examination

26 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05692.X

Emerging disease model for functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05692.X

Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05692.X

The role of the 5-HT4 receptor in Cl- secretion in human jejunal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05692.X

Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05692.X

Review article: tegaserod

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05692.X

Partial agonists and G protein-coupled receptor desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05692.X

Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05692.X

10.1111/J.1572-0241.2002.05692.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference